Correlation Between Chevron Corp and Mereo BioPharma
Can any of the company-specific risk be diversified away by investing in both Chevron Corp and Mereo BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Chevron Corp and Mereo BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Chevron Corp and Mereo BioPharma Group, you can compare the effects of market volatilities on Chevron Corp and Mereo BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Chevron Corp with a short position of Mereo BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Chevron Corp and Mereo BioPharma.
Diversification Opportunities for Chevron Corp and Mereo BioPharma
-0.63 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Chevron and Mereo is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Chevron Corp and Mereo BioPharma Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mereo BioPharma Group and Chevron Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Chevron Corp are associated (or correlated) with Mereo BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mereo BioPharma Group has no effect on the direction of Chevron Corp i.e., Chevron Corp and Mereo BioPharma go up and down completely randomly.
Pair Corralation between Chevron Corp and Mereo BioPharma
Considering the 90-day investment horizon Chevron Corp is expected to generate 31.11 times less return on investment than Mereo BioPharma. But when comparing it to its historical volatility, Chevron Corp is 3.72 times less risky than Mereo BioPharma. It trades about 0.01 of its potential returns per unit of risk. Mereo BioPharma Group is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 82.00 in Mereo BioPharma Group on August 27, 2024 and sell it today you would earn a total of 290.00 from holding Mereo BioPharma Group or generate 353.66% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Chevron Corp vs. Mereo BioPharma Group
Performance |
| Timeline |
| Chevron Corp |
| Mereo BioPharma Group |
Chevron Corp and Mereo BioPharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Chevron Corp and Mereo BioPharma
The main advantage of trading using opposite Chevron Corp and Mereo BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Chevron Corp position performs unexpectedly, Mereo BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mereo BioPharma will offset losses from the drop in Mereo BioPharma's long position.The idea behind Chevron Corp and Mereo BioPharma Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Mereo BioPharma vs. Terns Pharmaceuticals | Mereo BioPharma vs. PDS Biotechnology Corp | Mereo BioPharma vs. Inozyme Pharma | Mereo BioPharma vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |